Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Pritelivir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aicuris to Present Orally and via Poster at ID Week 2025
    Aicuris to Present Orally and via Poster at ID Week 2025

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150566/0/en/Aicuris-Announces-Upcoming-Oral-and-Poster-Presentations-at-ID-Week-2025.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Aicuris Completes Enrollment for Pritelivir Herpes Trial
    Aicuris Completes Enrollment for Pritelivir Herpes Trial

    24 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/24/3120818/0/en/Aicuris-Enrolled-Last-Participant-in-Pivotal-Trial-with-Pritelivir-to-Treat-Refractory-Herpes-Simplex-Infection-in-Immunocompromised-Patients.html

    GLOBENEWSWIRE
    24 Jul 2025
    Share Share
    AiCuris was Granted Breakthrough Therapy Designation by U.S. FDA for Pritelivir
    AiCuris was Granted Breakthrough Therapy Designation by U.S. FDA for Pritelivir

    06 Jun 2020

    // APNEWS

    https://apnews.com/fbb951ff5cc252c651f6a300e45c2365

    APNEWS
    06 Jun 2020
    Share Share